Vice President Science & Technology
Catalent Pharma Solutions
Julien Meissonnier was appointed Catalent’s Vice President, Science and Technology in 2015. In this role Mr. Meissonnier leads a dedicated global team of drug development and technology experts.
At any one time, Catalent is working on more than 500 new development projects and contributes to nearly 200 new product launches annually. Mr. Meissonnier had previously led Catalent’s European softgel R&D team, focused on early stage screening activities, developing products including OptiShell™ capsules and OptiGel™ Bio capsules, scale-up and technology transfer, directing clinical supplies, and supporting product launches. He holds an Engineering degree in Physico-Chemistry from the ENSI in Caen, France.